Sponsor hub
Sun Yat-sen University clinical trial failures
Review 54 stopped clinical trials from Sun Yat-sen University, including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 3 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OTHER/UNKNOWN
- 29
- OPERATIONAL
- 22
- SAFETY
- 2
- EFFICACY/FUTILITY
- 1
Notable sponsors
- Sun Yat-sen University
- 54
Related phases
- Phase II
- 35
- Phase III
- 13
- Phase I
- 2
- Phase IV
- 2
- Unknown
- 2
Crawlable stopped-trial records
Open ExploreShowing up to 54 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Phase II Soft Tissue Sarcoma trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
The study was terminated due to initiation of a new clinical trial with an updated study design.
Phase I Cervical Cancer trial by Sun Yat-sen University. Stop reason: EFFICACY/FUTILITY.
Five patients were enrolled in the study, but no treatment response was observed and all the patients had the best of response of prgressive disease. Given the lack of efficacy, the trial was terminated.
Phase II Small Cell Lung Cancer Limited Stage trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
Since the interim results of the ADRIATIC trial presented at the ASCO Annual Meeting in June 2024, the design of the control group is no longer consistent with current clinical practice.
Phase II Triple Negative Breast Cancer trial by Sun Yat-sen University. Stop reason: OPERATIONAL.
Difficulty accruing subjects the study accrual was closed.
Phase IV Airway Complication of Anaesthesia trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
The study was proactively suspended to ensure alignment with all applicable regulatory filing procedures. This decision was made to maintain adherence to institutional and compliance standards prior to study initiation.
Phase II Rectal Cancer trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
Due to errors in the previously submitted modification, we request to withdraw it and will submit a corrected update shortly.
Phase II Lung Cancer trial by Sun Yat-sen University. Stop reason: OPERATIONAL.
No patients enrolled.
Phase II Lung Cancer trial by Sun Yat-sen University. Stop reason: OPERATIONAL.
No patients enrolled.
Phase II Lung Cancer trial by Sun Yat-sen University. Stop reason: OPERATIONAL.
Slow accrual
Phase II Efficacy and Safety trial by Sun Yat-sen University. Stop reason: OPERATIONAL.
No patients enrolled.
Phase III Lung Cancer trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
Slow accural.
Phase III Chemotherapy-Related Cognitive Impairment trial by Sun Yat-sen University. Stop reason: OPERATIONAL.
Difficulty accruing subjects the study accrual was closed
Phase III Brain Metastases trial by Sun Yat-sen University. Stop reason: OPERATIONAL.
Difficulty accruing subjects the study accrual was closed
Phase II Metastatic Colorectal Cancer trial by Sun Yat-sen University. Stop reason: OPERATIONAL.
Due to slow patient recruiting. No patients were enrolled 12 months after study initiation.
Phase III Colorectal Cancer trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
The study was terminated prematurely due to FUDR production halt in China
Phase II Tocilizumab trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
For some personal reasons.
Phase II Hepatocellular Carcinoma trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
No patients join
Phase III Metastatic Colorectal Cancer trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
Production halt of FUDR in China
Unknown Advanced Hepatocellular Carcinoma trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
This is a sub-study of another one.
Phase II Non-small Cell Lung Cancer trial by Sun Yat-sen University. Stop reason: OPERATIONAL.
slow enrollment
Phase II Locally Advanced Non-small Cell Lung Cancer trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
Clincal decision based on previous results
Phase III Colon Cancer trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
Significant differences in conversion rate as well as R0 resection rate between the two groups.
Phase II Nasopharyngeal Neoplasms trial by Sun Yat-sen University. Stop reason: SAFETY.
Unacceptable toxicity (nasopharynx necrosis and massive hemorrhage)
Unknown Nasopharyngeal Carcinoma trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Diarrhea trial by Sun Yat-sen University. Stop reason: OPERATIONAL.
Participants have better treatment selection, resulting in a slow recruitment.
Phase II Carcinoma Breast Stage IV trial by Sun Yat-sen University. Stop reason: OPERATIONAL.
Difficulty accruing subjects the study accrual was closed
Phase II ICC trial by Sun Yat-sen University. Stop reason: OPERATIONAL.
no patients enrolled
Phase II ICC trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
no patient enrolled
Phase II Metastatic Breast Cancer trial by Sun Yat-sen University. Stop reason: OPERATIONAL.
Difficulty accruing subjects the study accrual was closed
Phase II Triple Negative Breast Cancer trial by Sun Yat-sen University. Stop reason: OPERATIONAL.
Difficulty accruing subjects the study accrual was closed
Phase III Metastatic Triple Negative Breast Cancer trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase I Advanced Lung Cancer trial by Sun Yat-sen University. Stop reason: SAFETY.
Serious adverse events
Phase II Intrahepatic Cholangiocarcinoma trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
Protocol modification
Phase III Hepatocellular Carcinoma trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
There were difficulties in implementation
Phase III Hepatocellular Carcinoma trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
Midterm analysis showed negative results.
Phase II Polypoidal Choroidal Vasculopathy trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
study protocol changed
Phase II Recurrent and Metastatic Nasopharyngeal Carcinoma trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Hepatocellular Carcinoma trial by Sun Yat-sen University. Stop reason: OPERATIONAL.
No participants enrolled
Phase II Hepatocellular Carcinoma trial by Sun Yat-sen University. Stop reason: OPERATIONAL.
No participants enrolled
Phase II Hepatocellular Carcinoma trial by Sun Yat-sen University. Stop reason: OPERATIONAL.
No participants enrolled
Phase II Hepatocellular Carcinoma trial by Sun Yat-sen University. Stop reason: OPERATIONAL.
No participants enrolled
Phase III Hepatocellular Carcinoma trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
No paritcipants enrolled
Phase III Hepatocellular Carcinoma trial by Sun Yat-sen University. Stop reason: OPERATIONAL.
No participants enrolled
Phase II Hepatocellular Carcinoma trial by Sun Yat-sen University. Stop reason: OPERATIONAL.
No participants enrolled
Phase II Non-Small Cell Lung Carcinoma trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Hepatocellular Carcinoma trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
protocol violation
Phase II Non-small Cell Lung Cancer trial by Sun Yat-sen University. Stop reason: OPERATIONAL.
The study have difficulty in recruiting subjectes
Phase II Relapse/Refractory Multiple Myeloma trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Relapse/Refractory Multiple Myeloma trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Lymphoma, Extranodal NK-T-Cell trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase III Lymphoma, Extranodal NK-T-Cell trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
The study is out of date
Phase II Treatment Refusal trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase IV Type 2 Diabetes Mellitus trial by Sun Yat-sen University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase III Renal Function Disorder trial by Sun Yat-sen University. Stop reason: OPERATIONAL.
The study was withdrawn prior to enrollment of first participant.